Type 2 Diabetes: Symptoms, Causes, and Diagnosis

Type 2 Diabetes Symptoms: What to Recognize and When to Act

Type 2 diabetes is the most common form of diabetes, accounting for approximately 90–95% of all diabetes cases — yet it is also one of the most frequently undiagnosed conditions in medicine, because the type 2 diabetes symptoms that develop as blood glucose rises can be subtle, gradual, and easily attributed to other causes like stress, aging, or a busy lifestyle. An estimated 8.5 million Americans with Type 2 diabetes are undiagnosed, meaning their condition is progressing and causing organ damage without any treatment or awareness. Understanding the full spectrum of symptoms — from the earliest, most subtle signs to the more recognizable classic presentations — and knowing how the condition is caused and diagnosed gives people the knowledge to act earlier and avoid years of unrecognized disease. Our guide on what is diabetes provides the foundational overview; this article focuses specifically on recognition, causes, and the diagnostic process for Type 2 diabetes.

Early Warning Signs of Type 2 Diabetes

Type 2 diabetes develops gradually over years — first as insulin resistance, then as prediabetes, and eventually as frank diabetes when insulin secretion can no longer compensate. In the early stages, blood glucose rises above normal but below the diagnostic thresholds for diabetes, and symptoms may be absent or extremely subtle. As blood glucose climbs into the diabetic range, the following early warning signs begin to emerge:

Increased thirst (polydipsia): When blood glucose is elevated above the renal threshold (approximately 180 mg/dL), glucose spills into the urine, pulling water with it through osmosis. The resulting fluid loss stimulates thirst — often described as unquenchable, particularly at night. This is one of the most consistent early symptoms of significantly elevated blood glucose.
Frequent urination (polyuria): The glucose-driven osmotic diuresis described above produces significantly increased urine output — often forcing people to wake multiple times at night to urinate (nocturia), a symptom that disrupts sleep and is sometimes the first symptom people consciously notice.
Increased hunger (polyphagia): When cells cannot efficiently take up glucose due to insulin resistance, the body interprets this as a starvation signal and increases hunger — even after eating. People with early Type 2 diabetes often eat more than usual without satisfying their hunger, and this increased caloric intake can compound weight gain and worsen insulin resistance.
Unexplained fatigue: Cells deprived of adequate glucose uptake — because insulin resistance prevents efficient glucose entry — produce less ATP, the cellular energy currency. The resulting fatigue is often described as a deep, pervasive tiredness that sleep does not resolve and that is qualitatively different from ordinary tiredness. Our guide on fatigue and blood sugar problems covers this symptom in detail.
Blurred vision: Elevated blood glucose changes the osmotic pressure within the lens of the eye, causing it to swell and alter its focal length — producing blurred vision that fluctuates with blood glucose levels. This is a temporary, reversible phenomenon in early diabetes (distinct from the irreversible diabetic retinopathy that develops with prolonged uncontrolled glucose), but it can be startling and is a meaningful early warning sign.

Progressive and Less-Recognized Symptoms

As Type 2 diabetes progresses — particularly in people who go undiagnosed or undertreated for years — additional symptoms develop that reflect the accumulating effects of chronically elevated glucose on nerves, blood vessels, kidneys, and the immune system:

Slow wound healing: High blood glucose impairs white blood cell function, reduces blood flow to peripheral tissues, and directly damages the small blood vessels that deliver oxygen and immune cells to wounds. Cuts, scrapes, and sores that would normally heal within days take weeks in people with poorly controlled diabetes. Our guide on slow wound healing and diabetes covers this symptom and when it warrants urgent medical attention.
Frequent infections: Elevated glucose provides a nutrient-rich environment for bacteria and fungi while simultaneously impairing the immune response — particularly the function of neutrophils (white blood cells that kill bacteria). Recurrent urinary tract infections, skin infections, yeast infections (particularly vaginal candidiasis in women and jock itch in men), and slow-resolving respiratory infections are all common in undiagnosed or poorly controlled Type 2 diabetes.
Tingling, numbness, or pain in hands and feet: Chronically elevated glucose damages peripheral nerves through a process called diabetic peripheral neuropathy — impairing sensation, causing burning pain, or producing the classic “pins and needles” tingling most pronounced in the feet and lower legs. Our guide on tingling feet and diabetes covers this specific symptom.
Darkened skin patches (acanthosis nigricans): Velvety, dark patches of skin — most commonly in the armpits, groin, back of the neck, and skin folds — are a sign of high circulating insulin levels (hyperinsulinemia) associated with insulin resistance. They often appear years before formal diabetes diagnosis and serve as a visible marker of significant underlying insulin resistance. Our guide on skin changes and diabetes covers this and other dermatological signs of the condition.
Unexplained weight loss: While most people associate Type 2 diabetes with excess weight, significant unexplained weight loss can occur when diabetes is severe enough that the body begins breaking down muscle and fat for energy because it cannot access blood glucose. This symptom is more common in Type 1 diabetes but can occur in advanced Type 2. Our guide on unexplained weight loss and diabetes explains when this symptom warrants urgent evaluation.

doctor explaining type 2 diabetes diagnosis results including A1C and fasting blood glucose tests — Type 2 diabetes is diagnosed using fasting blood glucose, A1C, or oral glucose tolerance tests — often as part of routine screening.

Causes of Type 2 Diabetes: How the Condition Develops

Type 2 diabetes develops through a sequence of metabolic failures rooted in insulin resistance — the reduced ability of cells to respond to insulin’s glucose-uptake signal. Several interconnected causes drive this progression:

Insulin resistance: The foundational cause of Type 2 diabetes is the failure of muscle, liver, and fat cells to respond normally to insulin. This failure is driven primarily by excess visceral fat (which releases inflammatory signals and free fatty acids that directly impair insulin signaling), physical inactivity (which reduces the muscle’s insulin-stimulated and contraction-stimulated glucose uptake), and genetic susceptibility (which determines how much insulin resistance develops at a given level of adiposity and inactivity). Our guide on what is insulin resistance covers the cellular mechanisms in detail.

Beta cell failure: For years or even decades before Type 2 diabetes develops, the pancreatic beta cells compensate for insulin resistance by producing more insulin. When insulin resistance progresses to the point that beta cells can no longer compensate — and when the chronic overwork and glucotoxicity of persistently elevated glucose begins to damage and exhaust beta cells — insulin secretion becomes inadequate relative to the degree of resistance, and blood glucose rises persistently into the diabetic range.

Liver glucose overproduction: In insulin-resistant states, the liver’s glucose production (gluconeogenesis) is no longer properly suppressed by insulin, producing excessive fasting glucose output even when blood glucose is already elevated. This elevated fasting glucose production contributes to the high fasting glucose readings that are one of the diagnostic criteria for Type 2 diabetes.

Genetic factors: Over 400 genetic variants have been identified that increase Type 2 diabetes risk. No single variant is deterministic, but their cumulative effect substantially modifies how much insulin resistance and beta cell dysfunction develop at a given level of lifestyle exposure. Family history of Type 2 diabetes reflects this genetic component — our guide on family history and diabetes risk covers the inheritance patterns in detail.

How Common Is Type 2 Diabetes? Approximately 37.3 million Americans — 11.3% of the U.S. population — have diabetes, with 90–95% of these cases being Type 2. An additional 96 million adults (38%) have prediabetes. Each year, approximately 1.4 million Americans receive a new diabetes diagnosis. Type 2 diabetes is the seventh leading cause of death in the United States.

Risk Factors for Type 2 Diabetes

Type 2 diabetes risk is determined by a combination of non-modifiable and modifiable factors. Understanding which factors apply to you helps identify who should be screened earlier and more aggressively:

Age 45 or older — risk rises with each decade after 45 due to age-related changes in beta cell function, muscle mass, and insulin sensitivity (see our guide on age and Type 2 diabetes risk)
Overweight or obesity — particularly central adiposity; BMI above 25 (or 23 in Asian adults) substantially elevates risk
Physical inactivity — sedentary behavior directly worsens insulin resistance; see our guide on sedentary lifestyle and blood sugar
Family history — a first-degree relative with Type 2 diabetes doubles to triples individual risk
Race/ethnicity — Black, Hispanic, Asian, and Native American adults face higher rates than non-Hispanic white adults (see our guide on ethnicity and diabetes risk)
History of prediabetes — the strongest single predictor of near-term Type 2 diabetes development
History of gestational diabetes — up to 50% lifetime risk of Type 2 diabetes after a gestational diabetes pregnancy
Polycystic ovary syndrome (PCOS) — androgen-driven insulin resistance makes PCOS a major diabetes risk factor in women
Metabolic syndrome — the cluster of abdominal obesity, high triglycerides, low HDL, hypertension, and elevated glucose; see our guide on metabolic syndrome and diabetes

How Type 2 Diabetes Is Diagnosed

Type 2 diabetes is diagnosed using one of three blood tests, any of which must be confirmed by repeat testing on a separate day unless the patient has unambiguous hyperglycemic symptoms and a random glucose above 200 mg/dL:

Fasting plasma glucose (FPG): A blood glucose level of 126 mg/dL or higher after at least 8 hours without food. Values between 100–125 mg/dL indicate prediabetes (impaired fasting glucose). Our guide on fasting blood sugar explained covers interpretation in detail.
A1C (glycated hemoglobin): A1C of 6.5% or higher indicates diabetes; 5.7–6.4% indicates prediabetes; below 5.7% is normal. A1C measures the average blood glucose over approximately 3 months and does not require fasting. Our guide on what the A1C test means explains this test fully.
Oral glucose tolerance test (OGTT): A 2-hour blood glucose of 200 mg/dL or higher after a standardized 75-gram glucose drink indicates diabetes; 140–199 mg/dL indicates prediabetes (impaired glucose tolerance). The OGTT is more sensitive than fasting glucose for detecting post-meal glucose dysregulation and is the standard test for gestational diabetes screening.

For most adults without symptoms, diabetes diagnosis occurs through routine screening — which the American Diabetes Association recommends beginning at age 35 for all adults, or earlier if risk factors are present. Our guide on what is normal blood sugar covers the full range of glucose values and what each level means clinically.

Who Should Be Screened for Type 2 Diabetes — and When

Because Type 2 diabetes develops silently over years and produces its most serious organ damage before symptoms are obvious, screening asymptomatic adults is one of the most important tools in the clinical management of the condition. The American Diabetes Association recommends the following screening approach for adults without symptoms:

All adults age 35 and older should be screened for prediabetes and Type 2 diabetes using a fasting glucose or A1C test at their next clinical visit, and every 3 years if results are normal.
Adults under 35 who are overweight or obese (BMI at or above 25 kg/m², or at or above 23 in Asian adults) and have one or more additional risk factors — family history, high-risk ethnicity, history of gestational diabetes, polycystic ovary syndrome, hypertension, HDL below 35 mg/dL, triglycerides above 250 mg/dL, or prior prediabetes — should be screened regardless of age.
Women with a history of gestational diabetes should be screened for Type 2 diabetes every 1–3 years throughout their lives, as their lifetime risk of Type 2 diabetes following a gestational diabetes pregnancy is 35–50%.
People with prediabetes (fasting glucose 100–125 mg/dL, A1C 5.7–6.4%, or 2-hour OGTT 140–199 mg/dL) should be screened annually, since prediabetes progression to Type 2 diabetes occurs at a rate of approximately 5–10% per year without intervention.

People who are screened and found to be normal can be rescreened every 3 years in the absence of new risk factors. Earlier or more frequent rescreening is appropriate if new risk factors develop — particularly significant weight gain, new hypertension or dyslipidemia, or a family history of early-onset Type 2 diabetes. Our guide on what is prediabetes covers the clinical definition, risk factors, and evidence-based prevention strategies for people who receive a prediabetes diagnosis on screening, since prediabetes is the most actionable risk stage — aggressive lifestyle intervention at this point can prevent or indefinitely delay progression to Type 2 diabetes.

It is worth noting that the current U.S. Preventive Services Task Force (USPSTF) recommendation for prediabetes and Type 2 diabetes screening is slightly different from the ADA: the USPSTF recommends screening adults age 35–70 who are overweight or obese. The ADA’s more inclusive recommendation based on all risk factors is generally preferred by endocrinologists and primary care physicians who see high-risk patients, since age cutoffs alone miss a meaningful proportion of at-risk adults — particularly younger adults from higher-risk ethnic groups and adults with multiple metabolic risk factors who develop diabetes in their 20s and 30s.

What Happens If Type 2 Diabetes Goes Undiagnosed or Untreated

Understanding the consequences of unrecognized or inadequately treated Type 2 diabetes is one of the most compelling arguments for aggressive screening and early treatment. The organ damage produced by chronically elevated blood glucose progresses silently and accumulates over years — and by the time complications become clinically obvious, significant irreversible damage has usually already occurred:

Cardiovascular disease: Adults with Type 2 diabetes have a 2–4 times higher risk of heart attack and stroke than adults without diabetes, and cardiovascular disease is the leading cause of death in people with Type 2 diabetes. The combination of endothelial dysfunction, accelerated atherosclerosis, hypertension, and dyslipidemia that accompany insulin resistance creates a dramatically adverse cardiovascular risk profile that begins years before formal diabetes diagnosis and worsens with each year of uncontrolled hyperglycemia. Our guide on what is insulin resistance covers the cardiovascular mechanisms of insulin resistance in detail.
Diabetic kidney disease (nephropathy): Elevated blood glucose damages the delicate filtration structures of the kidney’s glomeruli, producing progressive protein leakage into urine and declining kidney function. Diabetic nephropathy is the leading cause of chronic kidney disease and end-stage renal disease requiring dialysis in the United States — responsible for approximately 44% of new dialysis cases. The earliest sign of diabetic kidney disease is microalbuminuria (small amounts of the protein albumin in urine), detectable on screening before kidney function decline. Annual urine albumin screening is standard in Type 2 diabetes management.
Diabetic retinopathy: Elevated blood glucose damages the small blood vessels of the retina, producing a spectrum of changes from mild background retinopathy (small hemorrhages and microaneurysms with no vision impact) to proliferative diabetic retinopathy (new abnormal blood vessel growth that bleeds into the vitreous and can cause retinal detachment and blindness). Diabetic retinopathy is the leading cause of new cases of blindness in working-age adults in the United States. Annual dilated eye examinations are the standard of care for detecting retinopathy before vision-threatening changes develop.
Peripheral neuropathy and diabetic foot disease: Nerve damage from chronic hyperglycemia — combined with impaired circulation to the feet from peripheral arterial disease — produces the loss of protective sensation, foot deformity, and impaired wound healing that drive the devastating complication of diabetic foot ulcers and lower extremity amputations. Diabetes accounts for approximately 50–70% of all non-traumatic lower extremity amputations in the United States. Regular foot examinations and education about protective footwear and foot care are essential components of diabetes management.

The Cost of Late Diagnosis Studies show that people with Type 2 diabetes have typically had the condition for 4–7 years before diagnosis. During this unrecognized period, damage to blood vessels, kidneys, eyes, and nerves accumulates silently. Nearly 25% of people newly diagnosed with Type 2 diabetes already have evidence of end-organ complications at the time of their first diagnosis — making early screening not just cost-effective but medically critical for preventing irreversible damage.

Managing Type 2 Diabetes After Diagnosis: The First Steps

A Type 2 diabetes diagnosis initiates a structured process of evaluation, treatment planning, education, and monitoring. The first steps after diagnosis set the foundation for long-term metabolic control and complication prevention:

Comprehensive metabolic evaluation: The initial assessment after a new Type 2 diabetes diagnosis includes: baseline A1C to quantify current glycemic control; fasting lipid panel; kidney function tests (serum creatinine and urine albumin-to-creatinine ratio); liver function tests (relevant for fatty liver disease, which is common in insulin-resistant states); blood pressure measurement; dilated eye examination; and a comprehensive foot examination. These baseline measurements establish the starting point for all future monitoring and identify whether complications are already present.

Blood glucose targets: The standard A1C target for most non-pregnant adults with Type 2 diabetes is below 7.0% (corresponding to an average blood glucose of approximately 154 mg/dL). Less stringent targets (A1C below 8.0%) are appropriate for people with limited life expectancy, advanced complications, multiple comorbidities, or a history of severe hypoglycemia. More stringent targets (A1C below 6.5%) may be appropriate for younger people with newly diagnosed, mild diabetes who can achieve tight control without hypoglycemia through lifestyle alone. Our guide on what the A1C test means covers how to interpret A1C results and what the targets mean clinically.

Lifestyle intervention: Medical nutrition therapy and physical activity are the foundational treatments for Type 2 diabetes and produce meaningful reductions in A1C (1–2 percentage points) when implemented consistently. The ADA recommends working with a registered dietitian to develop an individualized eating plan, and at least 150 minutes per week of moderate-intensity aerobic activity combined with resistance training. Our guides on what foods raise blood sugar and sedentary lifestyle and blood sugar cover the dietary and physical activity components in detail.

Diabetes self-management education (DSME): Structured diabetes education — covering glucose monitoring, medication management, hypoglycemia recognition and treatment, sick day management, and foot care — is recommended at diagnosis, at transition points in care, and whenever there are complicating factors. Evidence consistently shows that people who receive formal DSME achieve better glycemic control, lower rates of diabetes complications, and better quality of life than those who manage the condition without formal education.

Key Takeaway: Symptoms Often Come Late Type 2 diabetes is unusual among serious chronic diseases in that its most dangerous period is the years before any symptoms appear. The damage to blood vessels, kidneys, and nerves begins when blood glucose first rises above normal — long before the classic symptoms of thirst, urination, and fatigue become noticeable. This is why screening based on risk factors, rather than waiting for symptoms, is the only reliable strategy for catching Type 2 diabetes before significant organ damage has occurred. Adults with risk factors who have not been screened recently should discuss a fasting glucose or A1C test with their healthcare provider, regardless of whether they feel unwell.

Sources: American Diabetes Association. “Standards of Medical Care in Diabetes.” Diabetes Care 2024. | CDC — National Diabetes Statistics Report 2022. | National Institute of Diabetes and Digestive and Kidney Diseases — Diabetes Symptoms and Causes. | Mayo Clinic — Type 2 Diabetes. | American Diabetes Association. “Classification and Diagnosis of Diabetes.” Diabetes Care 2024.